Analysis of Safety Outcomes in Chronic Hepatitis C Patients using Interferon-free Treatment: A Systematic Review of Case Reports
| Autor: | Letícia P. Leonart, Ana M. Della Rocca, Roberto Pontarolo, Vinicius Lins Ferreira |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
03 medical and health sciences
medicine.medical_specialty 0302 clinical medicine Chronic hepatitis business.industry 030220 oncology & carcinogenesis Internal medicine Interferon free medicine 030211 gastroenterology & hepatology Pharmacology (medical) General Pharmacology Toxicology and Pharmaceutics business |
| Zdroj: | Current Drug Therapy. 14:210-219 |
| ISSN: | 1574-8855 |
| Popis: | Background:Second generation direct acting-antivirals are safe and effective treatments for chronic hepatitis C patients.Objective:We aimed to conduct a systematic review of case reports and case series to evaluate the safety of the drugs, highlighting a compilation of AE not previously reported in other reviews.Methods:The search was performed in four electronic databases and included only case reports and case series that evaluated interferon-free therapies and provided safety outcomes.Results:Initially 1,235 records were retrieved, and after screening 30 studies were included in the analysis (23 case reports and 7 case series). A total of 39 patients were included, receiving eight different interferon-free treatments. Nineteen patients discontinued treatment (only 8 of these achieved treatment response). Other 19 patients achieved SVR without discontinuation. Rare adverse events were observed, including breast hypertrophy, retinopathy and drug-induced infection. Some patients were in an advanced stage of the disease, and were therefore unable to withstand treatment due to the appearance of complications.Conclusion:In this sense, it is important to monitor the use of these drugs that can favor the appearance of serious AE. (PROSPERO registration number CRD42016051680). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|